OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy
Manish Kumar, Abhishek Jha, Madhu Dr, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 10, pp. 1459-1472
Closed Access | Times Cited: 51
Manish Kumar, Abhishek Jha, Madhu Dr, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 10, pp. 1459-1472
Closed Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 10, pp. 3671-3718
Closed Access | Times Cited: 105
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 10, pp. 3671-3718
Closed Access | Times Cited: 105
Particle engineering in dry powders for inhalation
Regina Scherließ, Simon Bock, Nicholas Bungert, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 172, pp. 106158-106158
Open Access | Times Cited: 71
Regina Scherließ, Simon Bock, Nicholas Bungert, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 172, pp. 106158-106158
Open Access | Times Cited: 71
Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review
Mohit Kumar, Ayah Rebhi Hilles, Samah Hamed Almurisi, et al.
JCIS Open (2023) Vol. 12, pp. 100095-100095
Open Access | Times Cited: 48
Mohit Kumar, Ayah Rebhi Hilles, Samah Hamed Almurisi, et al.
JCIS Open (2023) Vol. 12, pp. 100095-100095
Open Access | Times Cited: 48
Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy
Chongzheng Yan, Y Liu, Guozhi Zhao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2281-2297
Open Access | Times Cited: 18
Chongzheng Yan, Y Liu, Guozhi Zhao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2281-2297
Open Access | Times Cited: 18
Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 130-157
Closed Access | Times Cited: 96
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 130-157
Closed Access | Times Cited: 96
CD-MOFs: From preparation to drug delivery and therapeutic application
Yanxue Si, Huize Luo, Pai Zhang, et al.
Carbohydrate Polymers (2023) Vol. 323, pp. 121424-121424
Closed Access | Times Cited: 34
Yanxue Si, Huize Luo, Pai Zhang, et al.
Carbohydrate Polymers (2023) Vol. 323, pp. 121424-121424
Closed Access | Times Cited: 34
Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment
Manish Kumar, Abhishek Jha, Kanchan Bharti, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113865-113865
Closed Access | Times Cited: 10
Manish Kumar, Abhishek Jha, Kanchan Bharti, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113865-113865
Closed Access | Times Cited: 10
Inhalable nanomedicine for lung cancer treatment
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 10
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 10
Nanocrystals: an emerging paradigm for cancer therapeutics
Ayush Patel, Krishi Patel, Viral Patel, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Ayush Patel, Krishi Patel, Viral Patel, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
Elide Zingale, Angela Bonaccorso, Claudia Carbone, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 691-691
Open Access | Times Cited: 29
Elide Zingale, Angela Bonaccorso, Claudia Carbone, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 691-691
Open Access | Times Cited: 29
Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis
Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1159-1191
Open Access | Times Cited: 21
Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1159-1191
Open Access | Times Cited: 21
Inhaled drug delivery: Past, present, and future
Ludan Yue, Xueyang Zhang, Chenchen Zhao, et al.
Nano Today (2023) Vol. 52, pp. 101942-101942
Closed Access | Times Cited: 19
Ludan Yue, Xueyang Zhang, Chenchen Zhao, et al.
Nano Today (2023) Vol. 52, pp. 101942-101942
Closed Access | Times Cited: 19
Nanocrystals: Characterization Overview, Applications in Drug Delivery, and Their Toxicity Concerns
Mohammed Asadullah Jahangir, Syed Sarim Imam, Abdul Muheem, et al.
Journal of Pharmaceutical Innovation (2020) Vol. 17, Iss. 1, pp. 237-248
Closed Access | Times Cited: 46
Mohammed Asadullah Jahangir, Syed Sarim Imam, Abdul Muheem, et al.
Journal of Pharmaceutical Innovation (2020) Vol. 17, Iss. 1, pp. 237-248
Closed Access | Times Cited: 46
Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review
Fakhara Sabir, Maimoona Qindeel, Mahira Zeeshan, et al.
Processes (2021) Vol. 9, Iss. 4, pp. 621-621
Open Access | Times Cited: 33
Fakhara Sabir, Maimoona Qindeel, Mahira Zeeshan, et al.
Processes (2021) Vol. 9, Iss. 4, pp. 621-621
Open Access | Times Cited: 33
A Review of Non-Invasive Drug Delivery through Respiratory Routes
Yongbo Zhang, Dong Xu, Lu Bai, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 27
Yongbo Zhang, Dong Xu, Lu Bai, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 27
Cationically Modified Inhalable Nintedanib Niosomes: Enhancing Therapeutic Activity Against Non-Small-Cell Lung Cancer
Snehal K. Shukla, Veronica Nguyen, Mimansa Goyal, et al.
Nanomedicine (2022) Vol. 17, Iss. 13, pp. 935-958
Open Access | Times Cited: 26
Snehal K. Shukla, Veronica Nguyen, Mimansa Goyal, et al.
Nanomedicine (2022) Vol. 17, Iss. 13, pp. 935-958
Open Access | Times Cited: 26
Formulation and validation of Candesartan cilexetil-loaded nanosuspension to enhance solubility
Sarmad Al-Edresi, Karrar Albo Hamrah, Abulfadhel Jaber Neamah Al-Shaibani
Pharmacia (2024) Vol. 71, pp. 1-13
Open Access | Times Cited: 4
Sarmad Al-Edresi, Karrar Albo Hamrah, Abulfadhel Jaber Neamah Al-Shaibani
Pharmacia (2024) Vol. 71, pp. 1-13
Open Access | Times Cited: 4
Current advances in the therapeutic potential of nanomedicines for pulmonary disorders
Mayank Sharma, Rahul K. Shah, Apeksha Saraf, et al.
Emergent Materials (2024)
Closed Access | Times Cited: 4
Mayank Sharma, Rahul K. Shah, Apeksha Saraf, et al.
Emergent Materials (2024)
Closed Access | Times Cited: 4
Fucoidan-based Bosutinib Nanocrystals for Pulmonary Drug Delivery: Solid State Characterization and In-vitro Assessment
Manish Kumar, Abhishek Jha, Kanchan Bharti, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100644-100644
Open Access | Times Cited: 4
Manish Kumar, Abhishek Jha, Kanchan Bharti, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100644-100644
Open Access | Times Cited: 4
Formulation and Evaluation of Lipid/Soluplus-Stabilized Nanocrystals of Paclitaxel and Bosutinib for a Synergistic Effect in Non-Small Cell Lung Cancer Therapy
Manish Kumar, Pooja Goswami, Abhishek Jha, et al.
Molecular Pharmaceutics (2025)
Closed Access
Manish Kumar, Pooja Goswami, Abhishek Jha, et al.
Molecular Pharmaceutics (2025)
Closed Access
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Nanocrystal Technology
Shudan Huang, Ting Zhang, Cuiping Shi, et al.
(2025), pp. 229-258
Closed Access
Shudan Huang, Ting Zhang, Cuiping Shi, et al.
(2025), pp. 229-258
Closed Access
Role of vesicular nanocarriers for the treatment of tuberculosis
Brojendra Nath Saren, Sayali Dighe, Saroj Kumar Jha, et al.
Elsevier eBooks (2025), pp. 99-145
Closed Access
Brojendra Nath Saren, Sayali Dighe, Saroj Kumar Jha, et al.
Elsevier eBooks (2025), pp. 99-145
Closed Access
Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy
Forough N Golafzani, Ali Zaman Vaziri, Masoud Javanmardi, et al.
Journal of Bioactive and Compatible Polymers (2022) Vol. 37, Iss. 3, pp. 168-188
Closed Access | Times Cited: 17
Forough N Golafzani, Ali Zaman Vaziri, Masoud Javanmardi, et al.
Journal of Bioactive and Compatible Polymers (2022) Vol. 37, Iss. 3, pp. 168-188
Closed Access | Times Cited: 17
Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
Y Zhang, Tongde Du, Na Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 9
Y Zhang, Tongde Du, Na Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 9
